Effects of COVID-19 pandemic on the management of pulmonary hypertension
- 26 November 2022
- journal article
- research article
- Published by Elsevier in Respiratory Medicine
- Vol. 206, 107061
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Monitoring Pulmonary Arterial Hypertension Using an Implantable Hemodynamic SensorChest, 2019
- Therapy for Pulmonary Arterial Hypertension in AdultsChest, 2019
- Risk stratification and medical therapy of pulmonary arterial hypertensionEuropean Respiratory Journal, 2019
- Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertensionEuropean Respiratory Journal, 2017
- Development of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT®) questionnaire: a new patient-reported outcome instrument for PAHRespiratory Research, 2016
- Utilization due to chronic obstructive pulmonary disease and its predictors: a study using the U.S. National Emergency Department Sample (NEDS)Respiratory Research, 2016
- emPHasis-10: development of a health-related quality of life measure in pulmonary hypertensionEuropean Respiratory Journal, 2013
- Referral of Patients With Pulmonary Hypertension Diagnoses to Tertiary Pulmonary Hypertension CentersJAMA Internal Medicine, 2013
- Prognostic factors in severe pulmonary hypertension patients who need parenteral prostanoid therapy: The impact of late referralThe Journal of Heart and Lung Transplantation, 2012
- The Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR): A Measure of Health-Related Quality of Life and Quality of Life for Patients with Pulmonary HypertensionQuality of Life Research, 2006